Document is current
Any future updates will be listed below
-
Authors
Sa, Jason K. https://orcid.org/0000-0002-3251-5004
Hong, Jung Yong
Lee, In-Kyoung
Kim, Ju-sun
Sim, Moon-Hee
Kim, Ha Jung
An, Ji Yeong
Sohn, Tae Sung
Lee, Joon Ho
Bae, Jae Moon
Kim, Sung
Kim, Kyoung-Mee
Kim, Seung Tae
Park, Se Hoon
Park, Joon Oh
Lim, Ho Yeong
Kang, Won Ki
Her, Nam-Gu
Lee, Yeri
Cho, Hee Jin
Shin, Yong Jae
Kim, Misuk
Koo, Harim
Kim, Mirinae
Seo, Yun Jee
Kim, Ja Yeon
Choi, Min-Gew
Nam, Do-Hyun
Lee, Jeeyun
-
Funding
Funding for this research was provided by:
Ministry of Health and Welfare (HI14C3418)
- License Information
-
More Information
Article History
Received: 5 August 2019
Accepted: 31 January 2020
First Online: 18 February 2020
Ethics approval and consent to participate
: The study was approved by the committee of Samsung Medical Center (SMC), Seoul, Republic of Korea (IRB file #201004004), on the use of human samples for experimental studies. Written informed consent was obtained from all study participants prior to enrollment. The research conformed to the principles of the Helsinki Declaration.
: Written informed consent was obtained from all study participants prior to enrollment.
: Do-Hyun Nam is the CEO of AimedBio Inc. and owns shares of AimedBio Inc. which owns IPs for Avatascan. The remaining authors declare that they have no competing interests.
